OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Perspectives on Mycophenolate Mofetil in the Management of Autoimmunity
R. G. Bhat, Antonio Tonutti, Suraj Timilsina, et al.
Clinical Reviews in Allergy & Immunology (2023) Vol. 65, Iss. 1, pp. 86-100
Closed Access | Times Cited: 15
R. G. Bhat, Antonio Tonutti, Suraj Timilsina, et al.
Clinical Reviews in Allergy & Immunology (2023) Vol. 65, Iss. 1, pp. 86-100
Closed Access | Times Cited: 15
Showing 15 citing articles:
Advancements in pharmacological interventions for atopic dermatitis current strategies and future directions
Yan Zhang, Shaoying Yuan, Yixing Wu, et al.
Inflammopharmacology (2025)
Closed Access
Yan Zhang, Shaoying Yuan, Yixing Wu, et al.
Inflammopharmacology (2025)
Closed Access
Mycophenolate Mofetil Inhibits Ferroptosis by Boosting Autophagy to Prevent Pulmonary Fibrosis
Weili Liu, Bo Liu, Hongbo Li, et al.
(2025)
Closed Access
Weili Liu, Bo Liu, Hongbo Li, et al.
(2025)
Closed Access
Mycophenolate mofetil exerts broad-spectrum antiviral activity against coronaviruses including SARS-CoV-2
Mengyuan Wu, Kun Wang, Huiqiang Wang, et al.
Virology Journal (2025) Vol. 22, Iss. 1
Open Access
Mengyuan Wu, Kun Wang, Huiqiang Wang, et al.
Virology Journal (2025) Vol. 22, Iss. 1
Open Access
Inmunosupresores en pacientes con manifestaciones neurológicas de patologías reumatológicas: revisión panorámica
Jairo Cajamarca-Barón, Diana Guavita-Navarro, Juan Esteban Bedoya Loaiza, et al.
Acta neurológica colombiana (2025) Vol. 41, Iss. 1
Open Access
Jairo Cajamarca-Barón, Diana Guavita-Navarro, Juan Esteban Bedoya Loaiza, et al.
Acta neurológica colombiana (2025) Vol. 41, Iss. 1
Open Access
Add‐on rituximab for primary heart involvement associated with systemic sclerosis: A step forward in the tailored treatment of myocarditis?
Maria De Santis, Antonio Tonutti, Francesca Motta, et al.
European Journal of Heart Failure (2024)
Open Access | Times Cited: 3
Maria De Santis, Antonio Tonutti, Francesca Motta, et al.
European Journal of Heart Failure (2024)
Open Access | Times Cited: 3
Clinical phenotype and outcome of persistent SARS-CoV-2 replication in immunocompromised hosts: a retrospective observational study in the Omicron era
Veronika Götz, Philipp Mathé, Prerana Agarwal, et al.
Infection (2023) Vol. 52, Iss. 3, pp. 923-933
Open Access | Times Cited: 3
Veronika Götz, Philipp Mathé, Prerana Agarwal, et al.
Infection (2023) Vol. 52, Iss. 3, pp. 923-933
Open Access | Times Cited: 3
Allograft persistence: The next frontier for allogeneic γδ T cell therapy
Daniel Fowler, Jonathan Fisher
Elsevier eBooks (2024), pp. 155-183
Closed Access
Daniel Fowler, Jonathan Fisher
Elsevier eBooks (2024), pp. 155-183
Closed Access
Tolosa-Hunt Syndrome as the Initial Presentation of Systemic Lupus Erythematosus
Fathima Nilofar, Kavitha Mohanasundaram, Mahendra Kumar, et al.
Cureus (2024)
Open Access
Fathima Nilofar, Kavitha Mohanasundaram, Mahendra Kumar, et al.
Cureus (2024)
Open Access
Therapeutic agents for steroid-refractory immune checkpoint inhibitor-related myocarditis: a narrative review
Yang Wang, Shouchao Li, He Shi, et al.
Cardiovascular Diagnosis and Therapy (2024) Vol. 14, Iss. 4, pp. 679-697
Open Access
Yang Wang, Shouchao Li, He Shi, et al.
Cardiovascular Diagnosis and Therapy (2024) Vol. 14, Iss. 4, pp. 679-697
Open Access
Autoantibodies, cutaneous subset and immunosuppressants contribute to the cancer risk in systemic sclerosis
Antonio Tonutti, Francesca Motta, Natasa Isailovic, et al.
RMD Open (2024) Vol. 10, Iss. 3, pp. e004492-e004492
Open Access
Antonio Tonutti, Francesca Motta, Natasa Isailovic, et al.
RMD Open (2024) Vol. 10, Iss. 3, pp. e004492-e004492
Open Access
Long-term retention rate, adverse event temporal patterns and rescue treatment strategies of mycophenolate mofetil in systemic sclerosis: insights from real-life
Enrico De Lorenzis, G. Natalello, Greta Pellegrino, et al.
Lara D. Veeken (2024)
Closed Access
Enrico De Lorenzis, G. Natalello, Greta Pellegrino, et al.
Lara D. Veeken (2024)
Closed Access
Mycophenolate mofetil after tacrolimus for refractory clinically amyopathic dermatomyositis: a case report
Gui-Chen Ling, Chang Su, Yongjie Guo, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Gui-Chen Ling, Chang Su, Yongjie Guo, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Mycophenolate Mofetil, an Inhibitor of Inosine Monophosphate Dehydrogenase, and Tofacitinib, a Janus Kinase Inhibitor, Attenuate Airway Inflammation and Hyperresponsiveness in a Mouse Model of Allergic Asthma
Bernard Kravčenia, Tomasz Maślanka
Molecules (2024) Vol. 29, Iss. 22, pp. 5293-5293
Open Access
Bernard Kravčenia, Tomasz Maślanka
Molecules (2024) Vol. 29, Iss. 22, pp. 5293-5293
Open Access
Population pharmacokinetic analysis in children with different diseases treated with mycophenolate mofetil — Integrated analysis of clinical trials and real-world clinical data
Jumpei Saito, Akimasa Yamatani, Miki Akabane, et al.
European Journal of Pharmaceutical Sciences (2024), pp. 106970-106970
Open Access
Jumpei Saito, Akimasa Yamatani, Miki Akabane, et al.
European Journal of Pharmaceutical Sciences (2024), pp. 106970-106970
Open Access
Mycophenolate mofetil exposure on embryonic and fetal ear development in rats during pregnancy
Qian Chen, Yang Zhang, Youqi Luo, et al.
Birth Defects Research (2023) Vol. 115, Iss. 15, pp. 1411-1423
Open Access
Qian Chen, Yang Zhang, Youqi Luo, et al.
Birth Defects Research (2023) Vol. 115, Iss. 15, pp. 1411-1423
Open Access
